Mr. Melis et al., EP 91073 prevents EP 80661-induced penile erection: new evidence for the existence of specific EP peptide receptors mediating penile erection, NEUROPHARM, 41(2), 2001, pp. 254-262
The effect of EP 91073, EP 51389, EP 70555 and EP 51216, peptide analogues
of the growth hormone releasing peptide hexarelin, on penile erection induc
ed by EP 80661 or EP 60761 injected into the paraventricular nucleus of the
hypothalamus, was studied in male rats. Of the above peptides only EP 9107
3 (0.2-1 mug) was found capable of reducing penile erection induced by EP 8
0661 or EP 60761, when given into the paraventricular nucleus. Despite its
ability to prevent EP peptide-induced penile erection, EP 91073 (1 mug) was
unable to prevent penile erection induced by the dopamine receptor agonist
apomorphine (50 ng), oxytocin (30 ng) and N-methyl-D-aspartic acid (50 ng)
, when given into the paraventricular nucleus 10 min prior to the above sub
stances. The EP 91073-induced prevention of penile erection occurred with a
reduction in the increase in nitric oxide production that occurs in the pa
raventricular nucleus concomitant to penile erection induced by EP 80661 an
d EP 60761, as measured by intracerebral vertical microdialysis. The presen
t results are in line with the hypothesis that EP 80661 and EP 60761 induce
penile erection by activating specific receptors in the paraventricular nu
cleus, located possibly in oxytocinergic neurons mediating penile erection,
and show that EP 91073 acts as an antagonist of these EP peptide receptors
mediating penile erection. (C) 2001 Elsevier Science Ltd. All rights reser
ved.